Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00123136 |
Recruitment Status : Unknown
Verified June 2006 by Weintraub, Michael I., MD, FACP, FAAN.
Recruitment status was: Recruiting
First Posted : July 22, 2005
Last Update Posted : July 4, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetic Neuropathies | Device: foot energizer | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 250 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial |
Study Start Date : | August 2005 |
Study Completion Date : | December 2006 |

- reduction of neuropathic foot pain
- improve quality of life
- serial changes in EDX, QST, autonomic functions, biopsy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- DPN stage 2 and 3; symptomatic > 6 months
Exclusion Criteria:
- Pacemaker in patient or mate

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00123136
Contact: Michael I. Weintraub, MD | 914-941-0788 | miwneuro@pol.net |
United States, New York | |
Michael I. Weintraub MD 325 S. Highland Avenue | Recruiting |
Briarcliff, New York, United States, 10510 | |
Sub-Investigator: Susan Wolert, Data |
Principal Investigator: | Michael Weintraub, MD | New York Medical College |
ClinicalTrials.gov Identifier: | NCT00123136 |
Other Study ID Numbers: |
2005-81440-DPN |
First Posted: | July 22, 2005 Key Record Dates |
Last Update Posted: | July 4, 2006 |
Last Verified: | June 2006 |
pulsed magnetic field therapy diabetic peripheral neuropathy neuromodulation |
diabetic peripheral neuropathic pain sleep benefit diabetic peripheral neuropathic functioning |
Peripheral Nervous System Diseases Diabetic Neuropathies Neuromuscular Diseases Nervous System Diseases |
Diabetes Complications Diabetes Mellitus Endocrine System Diseases |